Cargando…
Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma
BACKGROUND: Combined treatment with tyrosine kinase inhibitors (TKI) plus anti-PD-1 antibodies showed high anti-tumor efficacy and made conversion resection possible for patients with unresectable hepatocellular carcinoma (HCC). However, long-term survival has not been reported. METHODS: A cohort of...
Autores principales: | Zhu, Xiao-Dong, Huang, Cheng, Shen, Ying-Hao, Xu, Bin, Ge, Ning-Ling, Ji, Yuan, Qu, Xu-Dong, Chen, Lingli, Chen, Yi, Li, Mei-Ling, Zhu, Jin-Jin, Tang, Zhao-You, Zhou, Jian, Fan, Jia, Sun, Hui-Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085942/ https://www.ncbi.nlm.nih.gov/pubmed/36178565 http://dx.doi.org/10.1245/s10434-022-12530-z |
Ejemplares similares
-
Long-term Survival of Patients with Cholangiolocellular Carcinoma After Curative Hepatectomy
por: Ariizumi, Shun-ichi, et al.
Publicado: (2014) -
The Modified Glasgow Prognostic Score as a Predictor of Survival After Hepatectomy for Colorectal Liver Metastases
por: Nakagawa, Kazuya, et al.
Publicado: (2014) -
Parenchyma-Sparing Hepatectomy with Vascular Reconstruction Techniques for Resection of Colorectal Liver Metastases with Major Vascular Invasion
por: Ko, Saiho, et al.
Publicado: (2016) -
Does Using Indocyanine Green Fluorescence Imaging for Tumors Help in Determining the Safe Surgical Margin in Real-Time Navigation of Laparoscopic Hepatectomy? A Retrospective Study
por: Cai, Xinran, et al.
Publicado: (2022) -
Preventing Futile Liver Resection: A Risk-Based Approach to Surgical Selection in Major Hepatectomy for Colorectal Cancer
por: Fromer, Marc W., et al.
Publicado: (2021)